None listed
Conditions
Interventions
Medical Device : ? Patients selected as study subjects are randomly assigned to either the experimental group or the control group using an alternating allocation method based on their registration or
Sponsors
Hallym University Medical Center
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: · Study subjects will be selected if they meet all of the following criteria. 1. Patients diagnosed with benign prostatic hyperplasia (BPH) and scheduled for HoLEP or Rezum™ surgery 2. Males aged 50 to 79 years 3. American Society of Anesthesiologists (ASA) physical status classification of Class I or II 4. Patients who have received adequate explanation of the study purpose and procedures and have voluntarily provided informed consent
Exclusion criteria
Exclusion criteria: · Patients meeting any of the following criteria will be excluded from the study. 1. Patients with concomitant prostate cancer or bladder cancer 2. Patients diagnosed with urethral stricture or interstitial cystitis/bladder pain syndrome accompanied by pain 3. Patients with allergy or hypersensitivity to local anesthetics (lidocaine) 4. Patients currently taking anticoagulants or antiplatelet agents who cannot discontinue them 5. Patients with a history of neurogenic bladder 6. Patients with severe liver disease or severe renal impairment (serum creatinine > 2.0 mg/dL) 7. Patients who do not consent to participate in the study or who have difficulty adhering to the study procedures 8. Individuals deemed by the investigator to be unsuitable for participation in the clinical trial
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Complications and safety assessment, additional analgesic usage, patient satisfaction assessment, urinary function assessment | — |
Primary
| Measure | Time frame |
|---|---|
| Effect on reducing pain and bladder irritation symptoms | — |
Countries
Korea, Republic of
Contacts
Public ContactHwanik Kim
Hallym University Medical Center
Outcome results
None listed